Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 369)
Posted On: 05/01/2019 2:40:23 AM
Post# of 36566
Posted By: rjs9787
Re: jt_stk #3623
Many years ago. Part of my debates with Info/ Oral-lyn for Type 2, Ae37 as a combo approach (even joe back then 2012 at Digi argued against that years ago) are again new. I said for years at digi about pd-l1 and using AE37 as a combo. I said that in 2008. So patient- yes we are. I recall AE saying we’re doing our first combo vaccine. I wrote AE for the first time saying I bet it’s AE 37 and GP2? His assistant wrote back how could you know that? Everything there is unpublished? I said I just know by guessing but it’s two peptides. Eric said later interesting guess but I can’t say until public. I was right and he’d recall. That was before Joe. This new study with Keytruda is the right one to me. That’s the right combination. Pd-l1 although way back then I didn’t know of Keytruda per say. Joe and his team obviously did after they took over and so let’s go!













(2)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site